Published Date: 02 Mar 2023
The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.
Read Full NewsA 46-year-old woman developed disseminated sarcoidosis after an eyebrow tattoo, with lesions spreading to distant, nontattooed skin and bilateral hilar nodes.
The AVANT GUARD trial design stacked the odds in favor of PFA over antiarrhythmic drugs. Yet, the results are unconvincing to this electrophysiologist. Maybe not all PFA systems are created equal.
Corticosteroids are associated with reduced cough severity and improved cough-related quality of life in patients with hypersensitivity pneumonitis, but they do not reduce objective cough frequency.
Dr Anne Peters discusses the varying subtypes of diabetes.
Cardiologists Bob Harrington and Lisa Rosenbaum discuss the loss of trust in medicine, how it may reflect patients’ desire for agency, and strategies to earn it back.
A 20-year-old man on daily finasteride suffers an ischemic stroke with multifocal carotid stenoses and multiple prothrombotic genetic variants — could the drug be implicated?
Medical specialties in which most doctors think they have either a promising or grim near-term (next 3 years) future are revealed.
1.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
2.
A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.
3.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
4.
Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation
5.
Oleanolic acid from grapes may increase chemotherapy effectiveness
1.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
2.
TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances
3.
Integrative Clinical Genomics of Metastatic Cancer: Decoding Tumor Evolution for Precision Oncology
4.
MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps
5.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Navigating the Complexities of Ph Negative ALL - Part VIII
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation